Quick Takeaways
- AdvisorShares Trust filed SCHEDULE 13G for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB).
- Disclosed ownership: 5.9%.
- Date of event: 31 Dec 2024.
AdvisorShares Trust - 31 Dec 2024 SCHEDULE 13G Report for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB)
- Filing Manager
- AdvisorShares Trust
- Reporting Manager
- AdvisorShares Trust
- Symbol
- ENVB
- Shares outstanding
- 10,167,017 shares
- Disclosed Ownership
- 599,854 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Jan 2025, 17:04:53 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 02 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AdvisorShares Trust disclosed 5.9% ownership in Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Jan 2025, 17:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 5.9% | 599,854 | 599,854 | 0 | /s/ Stefanie Little | Stefanie Little - Chief Compliance Officer |